Search Results 761-770 of 8462 for 78%
About this study. Rheumatoid arthritis (RA) patients have a higher prevalence of subclinical atherosclerosis than the general population.
The purpose of this study is to develop, in close collaboration with stakeholders and the Mayo Clinic Spine Center, an evidence-based decision aid for the ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The first double-blind 72-week treatment period will assess the efficacy and safety of elafibranor on the resolution of NASH without ...
Irinotecan may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab and bevacizumab, ...
Dr. Gregory Poland 00:03. The FDA approved a new booster formulation. So, it's part the previous booster that we got and part a combination of BA.4 and 5.
... 78,#N/A,82.00 301000191,HC CYCLOSPORINE ASSAY,212,225.00, 301000192,HC CYSTATIN C,155,#N/A,165.00 301000197,HC DES GAMMA CARBOXY PROTHROMBIN,528,#N/A,560.00 ...
The purpose of this study is to determine the safety and efficacy of intrathecal treatment delivered to the cerebrospinal fluid (CSF) of mesenchymal stem cells ...
About this study. The objective of the study is to identify a population of healthy blood donors that would be willing to donate blood within short notice ...
This is also accompanied by an increase in myeloid differentiation in AML cells. CCS1477 has significant anti-tumour activity as a monotherapy in xenograft ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.